Effects of acute MDMA intoxication on mood and impulsivity: Role of the 5-HT2 and 5-HT1 receptors

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  van Wel, Janelle H P ^a   Kuypers, Kim P C ^a   Theunissen, Eef L ^a   Bosker, Wendy M ^a   Bakker, Katja ^a   Ramaekers, Johannes G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; KETANSERIN; PINDOLOL; PLACEBO; SEROTONIN 1 RECEPTOR; SEROTONIN 2 RECEPTOR;

ADULT; ANXIETY; AROUSAL; ARTICLE; CONFUSION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INTOXICATION; FEMALE; HUMAN; HUMAN EXPERIMENT; IMPULSIVENESS; LEARNING; MALE; MOOD; NORMAL HUMAN; PROFILE OF MOOD STATES; PROTEIN FUNCTION; RESPONSE TIME; TASK PERFORMANCE;

ADULT; AFFECT; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; LEARNING; LINEAR MODELS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; QUESTIONNAIRES; RECEPTORS, SEROTONIN, 5-HT1; RECEPTORS, SEROTONIN, 5-HT2; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS; TASK PERFORMANCE AND ANALYSIS; YOUNG ADULT;

EID: 84863638853     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040187     Document Type: Article

References (55)

1. Bosker WM, Kuypers KP, Conen S, Ramaekers JG, (2010) Dose-related effects of MDMA on psychomotor function and mood before, during, and after a night of sleep loss. Psychopharmacology (Berl) 209: 69-76.
2. Kuypers KPC, Wingen M, Samyn N, Limbert N, Ramaekers JG, (2007) Acute effects of nocturnal doses of MDMA on measures of impulsivity and psychomotor performance throughout the night. Psychopharmacology (Berl) 192: 111-119.
3. Ramaekers JG, Kuypers KPC, (2006) Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol. Neuropsychopharmacology 31: 1048-1055.
4. Vollenweider FX, Liechti ME, Gamma A, Greer G, Geyer M, (2002) Acute psychological and neurophysiological effects of MDMA in humans. J Psychoactive Drugs 34: 171-184.
5. Curran HV, Travill RA, (1997) Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low. Addiction 92: 821-831.
6. Morgan MJ, (1998) Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19: 252-264.
7. Young SN, Leyton M, (2002) The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels. Pharmacol Biochem Behav 71: 857-865.
8. Flory JD, Manuck SB, Matthews KA, Muldoon MF, (2004) Serotonergic function in the central nervous system is associated with daily ratings of positive mood. Psychiatry Res 129: 11-19.
9. Toker L, Amar S, Bersudsky Y, Benjamin J, Klein E, (2010) The biology of tryptophan depletion and mood disorders. Isr J Psychiatry Relat Sci 47: 46-55.
10. Schmidt CJ, (1987) Neurotoxicity of the Psychedelic Amphetamine, Methylenedioxymethamphetamine. The Journal of Pharmacology and Experimental Therapeutics 240: 1-7.
11. Parrott AC, (2012) MDMA and serotonergic neurotoxicity: the empirical evidence for its adverse effects in humans-no need for translation. Br J Pharmacol.
12. Bedi G, Hyman D, de Wit H, (2010) Is Ecstasy an "Empathogen"? Effects of +/-3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others. Biol Psychiatry.
13. Parrott AC, Lasky J, (1998) Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology (Berl) 139: 261-268.
14. Parrott AC, Lock J, Conner AC, Kissling C, Thome J, (2008) Dance clubbing on MDMA and during abstinence from Ecstasy/MDMA: prospective neuroendocrine and psychobiological changes. Neuropsychobiology 57: 165-180.
15. Verheyden SL, Hadfield J, Calin T, Curran HV, (2002) Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences. Psychopharmacology (Berl) 161: 23-31.
16. Fitzgerald PJ, (2011) A neurochemical yin and yang: does serotonin activate and norepinephrine deactivate the prefrontal cortex? Psychopharmacology (Berl) 213: 171-182.
17. Kirby LG, Zeeb FD, Winstanley CA, (2011) Contributions of serotonin in addiction vulnerability. Neuropharmacology.
18. Pattij T, Vanderschuren LJ, (2008) The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci 29: 192-199.
19. Kuypers KPC, Samyn N, Ramaekers JG, (2006) MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function. Psychopharmacology (Berl) 187: 467-475.
20. Butler GK, Montgomery AM, (2004) Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use. Drug Alcohol Depend 76: 55-62.
21. Morgan MJ, Impallomeni LC, Pirona A, Rogers RD, (2006) Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naive controls. Neuropsychopharmacology 31: 1562-1573.
22. Piechatzek M, Indlekofer F, Daamen M, Glasmacher C, Lieb R, et al. (2009) Is moderate substance use associated with altered executive functioning in a population-based sample of young adults? Hum Psychopharmacol 24: 650-665.
23. Quednow BB, Kuhn KU, Hoppe C, Westheide J, Maier W, et al. (2007) Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy"). Psychopharmacology (Berl) 189: 517-530.
24. Gouzoulis-Mayfrank E, Daumann J, (2009) Neurotoxicity of drugs of abuse-the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines. Dialogues Clin Neurosci 11: 305-317.
25. Reneman L, Endert E, de Bruin K, Lavalaye J, Feenstra MG, et al. (2002) The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain. Neuropsychopharmacology 26: 387-396.
26. Liechti ME, Saur MR, Gamma A, Hell D, Vollenweider FX, (2000) Psychological and physiological effects of MDMA ("ecstasy") after pretreatment with the 5-HT2 antagonist Ketanserin in healthy humans. Neuropsychopharmacology 23: 396-404.
27. Liechti ME, Vollenweider FX, (2001) Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies. Hum Psychopharmacol 16: 589-598.
28. Vollenweider FX, Studerus E, Hasler F, Paulus M, (2006) Role of 5-HT1A receptors in the acute effects of MDMA on cognition and emotion in humans. International Journal of Neuropsychopharmacology 9: S73-S73.
29. Anastasio NC, Stoffel EC, Fox RG, Bubar MJ, Rice KC, et al. (2011) Serotonin (5-hydroxytryptamine) 5-HT2A receptor: association with inherent and cocaine-evoked behavioral disinhibition in rats. Behav Pharmacol 22: 248-261.
30. Schreiber R, de Vry J, (1993) 5-HT1A receptor ligands in animal models of anxiety, impulsivity and depression: multiple mechanisms of action? Prog Neuropsychopharmacol Biol Psychiatry 17: 87-104.
31. Kuypers KPC, Ramaekers JG, (2005) Transient memory impairment after acute dose of 75 mg 3.4-Methylene-dioxymethamphetamine. Journal of Psychopharmacology 19: 633-639.
32. Kuypers KPC, Ramaekers JG, (2007) Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected. Psychopharmacology 189: 557-563.
33. Ramaekers JG, Kuypers KP, Wingen M, Heinecke A, Formisano E, (2009) Involvement of inferior parietal lobules in prospective memory impairment during acute MDMA (ecstasy) intoxication: an event-related fMRI study. Neuropsychopharmacology 34.
34. Brogden RN, Sorkin EM, (1990) Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease. Drugs 40: 903-949.
35. Rabiner EA, Gunn RN, Wilkins MR, Sargent PA, Mocaer E, et al. (2000) Drug action at the 5-HT(1A) receptor in vivo: autoreceptor and postsynaptic receptor occupancy examined with PET and [carbonyl-(11)C]WAY-100635. Nucl Med Biol 27: 509-513.
36. Sharpley AL, Elliott JM, Attenburrow MJ, Cowen PJ, (1994) Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors. Neuropharmacology 33: 467-471.
37. van Wel JH, Kuypers KP, Theunissen EL, Bosker WM, Bakker K, et al. (2011) Blockade of 5-HT(2) Receptor Selectively Prevents MDMA-Induced Verbal Memory Impairment. Neuropsychopharmacology 36: 1932-1939.
38. de Wit H, Enggasser JL, Richards JB, (2002) Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology 27: 813-825.
39. Kagan J, (1966) Reflection-impulsivity: the generality and dynamics of conceptual tempo. J Abnorm Psychol 71: 17-24.
40. Cairns E, Cammock T, (1978) Development of a more reliable version of the Matching Familiar Figures Test. Developmental Psychology 14: 555-560.
41. Perales JC, Verdejo-Garcia A, Moya M, Lozano O, Perez-Garcia M, (2009) Bright and dark sides of impulsivity: performance of women with high and low trait impulsivity on neuropsychological tasks. J Clin Exp Neuropsychol 31: 927-944.
42. Messer SB, Brodzinsky DM, (1981) Three year stability of reflection-impulsivity in young adolescents. Developmental Psychology 17: 848-850.
43. Salkind NJ, Wright JC, (1977) The development of reflection impulsivity and cognitive efficiency: An integrated model. Human Development 20: 377-387.
44. Fillmore MT, Rush CR, Hays L, (2002) Acute effects of oral cocaine on inhibitory control of behavior in humans. Drug Alcohol Depend 67: 157-167.
45. Logan GD, (1994) On the ability to inhibit though and action: a users' guide to the stop signal paradigm. In: Dagenbach D, Carr TH, editors. pp. 189-239 editors. Inhibitory processes in attention, memory and language. San Diego: Academic Press. pp.
46. Fillmore MT, Rush CR, (2006) Polydrug abusers display impaired discrimination-reversal learning in a model of behavioural control. J Psychopharmacol 20: 24-32.
47. Fillmore MT, Rush CR, Hays L, (2006) Acute effects of cocaine in two models of inhibitory control: implications of non-linear dose effects. Addiction 101: 1323-1332.
48. Liechti ME, Baumann C, Gamma A, Vollenweider FX, (2000) Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram. Neuropsychopharmacology 22: 513-521.
49. Parrott AC, Stuart M, (1997) Ecstasy (MDMA), amphetamine, and LSD: Comparative mood profiles in recreational polydrug users. Human Psychopharmacology-Clinical and Experimental 12: 501-504.
50. Hasler F, Studerus E, Lindner K, Ludewig S, Vollenweider FX, (2009) Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA. Journal of Psychopharmacology 23: 923-935.
51. Talpos JC, Wilkinson LS, Robbins TW, (2006) A comparison of multiple 5-HT receptors in two tasks measuring impulsivity. J Psychopharmacol 20: 47-58.
52. Chambers CD, Garavan H, Bellgrove MA, (2009) Insights into the neural basis of response inhibition from cognitive and clinical neuroscience. Neurosci Biobehav Rev 33: 631-646.
53. Dalley JW, Everitt BJ, Robbins TW, (2011) Impulsivity, compulsivity, and top-down cognitive control. Neuron 69: 680-694.
54. Evenden JL, (1999) Varieties of impulsivity. Psychopharmacology (Berl) 146: 348-361.
55. Friedman NP, Miyake A, (2004) The relations among inhibition and interference control functions: a latent-variable analysis. J Exp Psychol Gen 133: 101-135.